tizanidine hydrochloride

Generic: tizanidine hydrochloride

Labeler: advagen pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine hydrochloride
Generic Name tizanidine hydrochloride
Labeler advagen pharma limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 6 mg/1

Manufacturer
Advagen Pharma Limited

Identifiers & Regulatory

Product NDC 72888-003
Product ID 72888-003_3f9bf106-484a-1c3c-e063-6394a90ac8a6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213798
Listing Expiration 2026-12-31
Marketing Start 2020-05-27

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72888003
Hyphenated Format 72888-003

Supplemental Identifiers

RxCUI
485484 485485 485486 2723708
UPC
0372888002156 0372888003153 0372888001159 0372888161150
UNII
B53E3NMY5C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine hydrochloride (source: ndc)
Generic Name tizanidine hydrochloride (source: ndc)
Application Number ANDA213798 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/1
source: ndc
Packaging
  • 150 CAPSULE in 1 BOTTLE (72888-003-15)
source: ndc

Packages (1)

Ingredients (1)

tizanidine hydrochloride (6 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3f9bf106-484a-1c3c-e063-6394a90ac8a6", "openfda": {"upc": ["0372888002156", "0372888003153", "0372888001159", "0372888161150"], "unii": ["B53E3NMY5C"], "rxcui": ["485484", "485485", "485486", "2723708"], "spl_set_id": ["7f39499a-98cf-4d13-9b07-ccb5c22e43c8"], "manufacturer_name": ["Advagen Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 CAPSULE in 1 BOTTLE (72888-003-15)", "package_ndc": "72888-003-15", "marketing_start_date": "20200527"}], "brand_name": "tizanidine hydrochloride", "product_id": "72888-003_3f9bf106-484a-1c3c-e063-6394a90ac8a6", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "72888-003", "generic_name": "tizanidine hydrochloride", "labeler_name": "Advagen Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tizanidine hydrochloride", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "6 mg/1"}], "application_number": "ANDA213798", "marketing_category": "ANDA", "marketing_start_date": "20200527", "listing_expiration_date": "20261231"}